Viatris (VTRS) Net Cash Flow (2019 - 2026)
Viatris (VTRS) posted quarterly Net Cash Flow of $461.9 million for Q1 2026, up 13485.29% year-over-year from N/an in Q1 2025, and up 25.45% quarter-over-quarter from $368.2 million in Q4 2025.
Viatris (VTRS) Net Cash Flow (2019 - 2026) Analysis & Trends
Viatris' Net Cash Flow history runs 8 years deep, the most recent figure standing at $461.9 million for Q1 2026.
- In Q1 2026, Net Cash Flow rose 13485.29% year-over-year to $461.9 million; the TTM figure through Mar 2026 stood at $1.1 billion (up 507.9% YoY), while the FY2025 annual figure was $594.3 million, up 362.04% from the prior year.
- Net Cash Flow for Q1 2026 stood at $461.9 million, up from $368.2 million in the prior quarter.
- The five-year high for Net Cash Flow was $937.7 million in Q3 2024, with the low at -$1.1 billion in Q4 2024.
- The 5-year median for Net Cash Flow is $34.7 million (2024), against an average of $68.1 million.
- Peak annual rise in Net Cash Flow reached 14625.53% in 2023, while the deepest fall reached 1302.88% in 2023.
- Viatris' Net Cash Flow stood at $596.5 million in 2022, then plunged by 155.47% to -$330.9 million in 2023, then sank by 234.3% to -$1.1 billion in 2024, then jumped by 133.29% to $368.2 million in 2025, then grew by 25.45% to $461.9 million in 2026.
- Business Quant data shows VTRS's Net Cash Flow at $461.9 million in Q1 2026, $368.2 million in Q4 2025, and $417.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 159.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -912.40 Mn |
| Jun 30, 2026 | -912.40 Mn |
| Mar 31, 2026 | 461.90 Mn |
| Mar 31, 2026 | 461.90 Mn |
| Dec 31, 2025 | 368.20 Mn |
| Dec 31, 2025 | 368.20 Mn |
| Sep 30, 2025 | 417.90 Mn |
| Sep 30, 2025 | 417.90 Mn |
| Jun 30, 2025 | -195.20 Mn |
| Jun 30, 2025 | -195.20 Mn |
| Mar 31, 2025 | 3.40 Mn |
| Mar 31, 2025 | 3.40 Mn |
| Dec 31, 2024 | -1.11 Bn |
| Dec 31, 2024 | -1.11 Bn |
| Sep 30, 2024 | 937.70 Mn |
| Sep 30, 2024 | 937.70 Mn |
| Jun 30, 2024 | -93.00 Mn |
| Jun 30, 2024 | -93.00 Mn |
| Mar 31, 2024 | 34.70 Mn |
| Mar 31, 2024 | 34.70 Mn |